Development and validation of prognostic nomogram for T
Curative resection
Nomogram
Non-small cell lung cancer
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
31 Jul 2023
31 Jul 2023
Historique:
received:
24
08
2022
accepted:
06
07
2023
medline:
2
8
2023
pubmed:
1
8
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Radical resection plus lymph node dissection is a common treatment for patients with T This study involved 3002 patients with T Age, sex, histological classification, pathological T stage, and HI standard were independent factors for OS and were included in our nomogram. The C-index of the nomogram for OS estimates were 0.671 (95% CI, 0.637-0.705),0.632 (95% CI, 0.581-0.683), and 0.645 (95% CI, 0.617-0.673) in the training cohorts, internal validation cohorts, and external validation cohort, respectively. The calibration plots and DCA for predictions of OS were in excellent agreement. An online version of the nomogram was built for convenient clinical practice. Our nomogram can predict the OS of patients with T
Sections du résumé
BACKGROUND
BACKGROUND
Radical resection plus lymph node dissection is a common treatment for patients with T
MATERIALS AND METHODS
METHODS
This study involved 3002 patients with T
RESULTS
RESULTS
Age, sex, histological classification, pathological T stage, and HI standard were independent factors for OS and were included in our nomogram. The C-index of the nomogram for OS estimates were 0.671 (95% CI, 0.637-0.705),0.632 (95% CI, 0.581-0.683), and 0.645 (95% CI, 0.617-0.673) in the training cohorts, internal validation cohorts, and external validation cohort, respectively. The calibration plots and DCA for predictions of OS were in excellent agreement. An online version of the nomogram was built for convenient clinical practice.
CONCLUSIONS
CONCLUSIONS
Our nomogram can predict the OS of patients with T
Identifiants
pubmed: 37525124
doi: 10.1186/s12885-023-11158-w
pii: 10.1186/s12885-023-11158-w
pmc: PMC10391852
doi:
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
715Informations de copyright
© 2023. The Author(s).
Références
Cancers (Basel). 2021 Apr 17;13(8):
pubmed: 33920510
Transl Lung Cancer Res. 2021 Jun;10(6):2715-2732
pubmed: 34295672
J Natl Compr Canc Netw. 2021 Mar 02;19(3):254-266
pubmed: 33668021
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
J Thorac Oncol. 2019 Jun;14(6):968-978
pubmed: 30851441
Lung Cancer. 2021 Dec;162:54-60
pubmed: 34739854
Ann Surg Oncol. 2021 Sep;28(9):4893-4904
pubmed: 33655361
Cureus. 2019 Oct 11;11(10):e5889
pubmed: 31772859
Ann Transl Med. 2019 Jul;7(Suppl 3):S107
pubmed: 31576314
J Thorac Oncol. 2018 Jun;13(6):767-778
pubmed: 29654928
Lung Cancer. 2005 May;48(2):241-6
pubmed: 15829324
Front Genet. 2018 Nov 22;9:568
pubmed: 30524472
Transl Lung Cancer Res. 2021 Dec;10(12):4587-4599
pubmed: 35070763
J Clin Oncol. 2017 Feb 10;35(5):572-573
pubmed: 27893336
Lancet Oncol. 2019 Jan;20(1):23-25
pubmed: 30614461
Lancet Oncol. 2015 Apr;16(4):e173-80
pubmed: 25846097
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Oncol. 2021 Sep 08;11:683282
pubmed: 34568016
J Clin Oncol. 2015 Mar 10;33(8):861-9
pubmed: 25624438
Ann Surg Oncol. 2021 Jul;28(7):3941-3950
pubmed: 33249521
Eur J Cardiothorac Surg. 2019 Apr 1;55(4):682-690
pubmed: 30508081
JAMA Oncol. 2018 Jan 01;4(1):80-87
pubmed: 28973110
Ann Surg Oncol. 2022 Mar;29(3):1868-1879
pubmed: 34613537
Am J Respir Crit Care Med. 2022 Feb 15;205(4):P7-P8
pubmed: 35166649
Ther Adv Med Oncol. 2020 Nov 05;12:1758835920970063
pubmed: 33224277
J Natl Compr Canc Netw. 2020 Feb;18(2):143-150
pubmed: 32023528
Transl Lung Cancer Res. 2021 Feb;10(2):815-825
pubmed: 33718024